![David Cutler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Cutler
Corporate Officer/Principal chez ATHENEXPAR
Profil
David Cutler is currently working as the Deputy Chief Medical Officer-Biologics at Athenex, Inc. He holds a doctorate degree from the University of Saskatchewan.
Postes actifs de David Cutler
Sociétés | Poste | Début |
---|---|---|
ATHENEXPAR | Corporate Officer/Principal | - |
Formation de David Cutler
University of Saskatchewan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Athenex, Inc.
![]() Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |